, Volume 42, Issue 3, pp 555–560 | Cite as

Insulin resistance and acne: a new risk factor for men?

  • Michela Del Prete
  • Maria Chiara Mauriello
  • Antongiulio FaggianoEmail author
  • Carolina Di Somma
  • Giuseppe Monfrecola
  • Gabriella Fabbrocini
  • Annamaria Colao
Original Article


The purpose of this study is to investigate the relationship between acne and insulin resistance as well as other metabolic impairment in young males. Acne is a skin disease that can be influenced by endocrine abnormalities. In females, it is associated with polycystic ovary syndrome, with peripheral insulin resistance and hyperinsulinemia, whereas few data are available in males. For investigating this, 22 young males with acne have been compared to 22 controls of comparable age and gender. Acne was scored using the global acne grading system score. Clinical as well as biochemical parameters of glucose and lipid metabolism, circulating levels of androgens, and IGF-1 were evaluated. Oral glucose tolerance test was performed and homeostasis model assessment of insulin resistance was calculated. The results thus obtained are as follows, patients had higher BMI (p = 0.003), WC (p = 0.002), WHR (p = 0.02), SBP (p = 0.0001), DBP (p = 0.001), basal (p = 0.01) and 120 min. oGTT serum insulin concentrations (p = 0.002), basal glucose concentrations (p = 0.03), HOMA-IR (p = 0.016), and lower HDL-cholesterol than controls (p = 0.001). Among the subgroup of subjects with BMI <24.9, HDL-cholesterol (p = 0.05) and 120 min. oGTT serum insulin concentrations (p = 0.009) resulted to be independent predictors of acne at multivariate analysis. In conclusion, these findings highlight a metabolic imbalance in young males affected with acne. Insulin resistance seems to play the main role for the development of acne in these subjects. Insulin resistance could represent an effective target for therapy in male acne.


Acne Male acne Insulin Insulin resistance HDL-cholesterol 



We are extremely grateful to all volunteers who took part in these studies and the research teams who collected the data.

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.


  1. 1.
    V. Bataille, H. Snieder, A.J. MacGregor, P. Sasieni, T.D. Spector, The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J. Invest. Dermatol. 119(6), 1317–1322 (2002)PubMedCrossRefGoogle Scholar
  2. 2.
    L. Cordain, S. Lindeberg, M. Hurtado, K. Hill, B. Eaton, B. Brand-Miller, Acne vulgaris-a disease of western civilization. Arch. Dermatol. 138, 1584–1590 (2002)PubMedCrossRefGoogle Scholar
  3. 3.
    G. Plewig, A.M. Kligman, Acne and Rosacea, 3rd edn. (Springer, Berlin, 2000)CrossRefGoogle Scholar
  4. 4.
    W. Chen, D. Thiboutot, C.C. Zouboulis, Cutaneous androgen metabolism: basic research and clinical perspectives. J. Invest. Dermatol. 119(5), 992–1007 (2002)PubMedCrossRefGoogle Scholar
  5. 5.
    R.L. Rosenfield, D. Deplewski, Role of androgens in the developmental biology of the pilosebaceous unit. Am. J. Med. 98, 80S–88S (1995)PubMedCrossRefGoogle Scholar
  6. 6.
    J.F. Cara, R. Rosenfield, R. Furlanetto, A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am. J. Dis. Child. 141, 562–564 (1987)PubMedGoogle Scholar
  7. 7.
    M. Cappel, D. Mauger, D. Thiboutot, Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch. Dermatol. 141(3), 333–338 (2005)PubMedCrossRefGoogle Scholar
  8. 8.
    D. Deplewski, R. Rosenfield, Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 140, 4089–4094 (1999)PubMedCrossRefGoogle Scholar
  9. 9.
    H. Aizawa, M. Niimura, Elevated serum insulin-like growth factor-I (IGF-1) levels in women with postadolescent acne. J. Dermatol. 22, 249–252 (1995)PubMedGoogle Scholar
  10. 10.
    L. Speroff, M.A. Fritz, Anovulation and the polycystic ovary, in Clinical Gynecologic Endocrinology and Infertility, 7th edn., ed. by L. Speroff, M.A. Fritz (Lippincott Williams & Wilkins, Philadelphia, 2005), pp. 470–483Google Scholar
  11. 11.
    R. Azziz, Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil. Steril. 83(5), 1343–1346 (2005)PubMedCrossRefGoogle Scholar
  12. 12.
    Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19(1), 41–47 (2004)CrossRefGoogle Scholar
  13. 13.
    R.N. Smith, N.J. Mann, A. Braue, H. Makelainen, G.A. Varigos, A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am. J. Clin. Nutr. 86, 107–115 (2007)PubMedGoogle Scholar
  14. 14.
    A. Nast, B. Dréno, V. Bettoli et al. Guidelines on the treatment of acne. European evidence based. European Dermatology Forum 2011Google Scholar
  15. 15.
    A. Doshi, A. Zaheer, M.J. Stiller, A comparison of current acne grading systems and proposal of a novel system. Int. J. Dermatol. 36(6), 416–418 (1997)PubMedCrossRefGoogle Scholar
  16. 16.
    World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation, Geneva, 2000Google Scholar
  17. 17.
    World Health Organization. Waist Circumference and Waist–Hip Ratio. Report of a WHO Expert Consultation, Geneva, 8–11 Dec 2008Google Scholar
  18. 18.
    G. Mansia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A.M. Heagerty, S.E. Kjeldsen, S. Laurent, K. Narkiewicz, L. Ruilope, A. Rynkiewicz, R.E. Schmieder, H.A. Struijker Boudier, A. Zanchetti, European Society of Hypertension; European Society of Cardiology. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press. 16(3), 135–232 (2007)PubMedCrossRefGoogle Scholar
  19. 19.
    D. Macut, D. Vojnović Milutinović, I. Božić, G. Matić, J. Brkljačić, D. Panidis, M. Petakov, N. Spanos, J. Bjekić, O. Stanojlović, A. Petrović Milinković, Z. Radojičić, S. Damjanović, Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome. Endocrine 37(1), 129–134 (2010)PubMedCrossRefGoogle Scholar
  20. 20.
    B. Dilbaz, E. Ozkaya, M. Cinar, E. Cakir, S. Dilbaz, Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes. Endocrine 39(3), 272–277 (2011)PubMedCrossRefGoogle Scholar
  21. 21.
    Bahíllo-Curieses, M.P., Hermoso-López, F., Martínez-Sopena, M.J., Cobreros-García, P., García-Saseta, P., Tríguez-García, M., Marugán-Miguelsanz, J.M. Prevalence of insulin resistance and impaired glucose tolerance in a sample of obese spanish children and adolescents. Endocrine 41(2), 289–295 (2012)Google Scholar
  22. 22.
    C.H. Tsai, T.C. Li, C.C. Lin, H.S. Tsay, Factor analysis of modifiable cardiovascular risk factors and prevalence of metabolic syndrome in adult Taiwanese. Endocrine 40(2), 256–264 (2011)PubMedCrossRefGoogle Scholar
  23. 23.
    D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher, R. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologica 28, 412–419 (1985)CrossRefGoogle Scholar
  24. 24.
    R.N. Smith, N.J. Mann, A. Braue, H. Mäkeläinen, G.A. Varigos, The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J. Am. Acad. Dermatol. 57(2), 247–256 (2007)PubMedCrossRefGoogle Scholar
  25. 25.
    R.N. Smith, N. Mann, H. Mäkeläinen, J. Roper, A. Braue, G. Varigos, A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial. Mol. Nutr. Food Res. 52(6), 718–726 (2008)PubMedCrossRefGoogle Scholar
  26. 26.
    K.N. Whitaker, Polycystic ovary syndrome: an overview. J. Pharm. Pract. 24(1), 94–101 (2011)PubMedCrossRefGoogle Scholar
  27. 27.
    L.G. Nardo, S. Patchava, I. Laing, Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications. Panminerva. Med. 50(4), 267–278 (2008)PubMedGoogle Scholar
  28. 28.
    M.L. Fernandez, J.J. Jones, D. Ackerman, J. Barona, M. Calle, M.V. Comperatore, J.E. Kim, C. Andersen, J.O. Leite, J.S. Volek, M. McIntosh, C. Kalynych, W. Najm, R.H. Lerman, Low HDL cholesterol is associated with increased atherogenic lipoproteins and insulin resistance in women classified with metabolic syndrome. Nutr. Res. Pract. 4(6), 492–498 (2010)PubMedCrossRefGoogle Scholar
  29. 29.
    M.K. Arora, S. Seth, S. Dayal, The relationship of lipid profile and menstrual cycle with acne vulgaris. Clin. Biochem. 43(18), 1415–1420 (2010)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Michela Del Prete
    • 1
  • Maria Chiara Mauriello
    • 2
  • Antongiulio Faggiano
    • 1
    Email author
  • Carolina Di Somma
    • 1
  • Giuseppe Monfrecola
    • 2
  • Gabriella Fabbrocini
    • 2
  • Annamaria Colao
    • 1
  1. 1.Department of Molecular and Clinical Endocrinology and OncologyFederico II University of NaplesNaplesItaly
  2. 2.Systematic Pathology, Division of Clinical DermatologyFederico II University of NaplesNaplesItaly

Personalised recommendations